The New York Times
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
View original source — The New York Times ↗
Related stories
CNBC
WorldJun 8, 2026 · 1 min
Weight loss drug maker sinks 25% after new safety data spooks investors
CNBC
Bloomberg
HealthJun 8, 2026 · 1 min
Tango Soars as Study Shows Its Drug Can Help Shrink Tumors
Bloomberg
Nature
TechnologySep 2, 2026 · 1 min
Landmark pancreatic cancer drug shows potential against lung cancer too
Nature
The Hill
PoliticsSep 4, 2026 · 1 min
Epinephrine injection recalled over potentially fatal health risks
The Hill